Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Jun 16, 2024; 12(17): 3027-3034
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.3027
Table 1 Baseline information
Indicators
Control group (n = 75)
Research group (n = 85)
χ2/t value
P value
Sex (male/female)45/3049/360.0910.763
Age (yr)56.97 ± 10.0157.41 ± 9.020.2920.770
Disease course (yr)6.04 ± 1.165.88 ± 1.440.7670.444
NYHA cardiac function classification (II/III)34/4140/450.0480.827
Hypertension (with/without)38/3736/491.1080.293
DM (with/without)25/5031/540.1720.678
Hyperlipidemia (with/without)28/4735/500.2470.620
Table 2 Curative effects of traditional Chinese medicine syndromes, n (%)
Indicators
Control group (n = 75)
Research group (n = 85)
χ2 value
P value
Marked effectiveness24 (32.00)44 (51.76)
Effectiveness40 (53.33)39 (45.88)
Ineffectiveness8 (10.67)2 (2.35)
Exacerbation3 (4.00)0 (0.00)
Total effective rate64 (85.33)83 (97.65)8.0930.004
Table 3 Curative effects of cardiac function, n (%)
Indicators
Control group (n = 75)
Research group (n = 85)
χ2 value
P value
Marked effectiveness23 (30.67)43 (50.59)
Effectiveness39 (52.00)38 (44.71)
Ineffectiveness11 (14.67)4 (4.71)
Exacerbation2 (2.67)0 (0.00)
Total effective rate62 (82.67)81 (95.29)6.6900.010
Table 4 Major adverse cardiovascular events at 6-month follow-up, n (%)
Indicators
Control group (n = 75)
Research group (n = 85)
χ2 value
P value
Sudden cardiac death3 (4.00)2 (2.35)
Ventricular arrhythmia6 (8.00)3 (3.53)
Rehospitalization for heart failure10 (13.33)3 (3.53)
MACEs19 (25.33)8 (9.41)7.2000.007